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nocturnal GERD cases reported less non-prescription
medication use than younger adults (9.5% versus 22.5%;
p < 0.05) for GERD-related symptoms. CONCLUSIONS:
Symptomatic GERD and nocturnal GERD were less
prevalent and severe in elderly compared to younger
adults. Elderly reported less medication use for GERD-
related sysptoms than younger adults.
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GASTROESOPHAGEAL REFLUX IN INFANTS:
IMPACT ON THE QOL OF PARENTS
Taïeb C, Marionneau N, Myon E
Pierre Fabre SA, Boulogne Billancourt, France
Very common in infants, gastroesophageal reﬂux causes
regurgitations which generally disappear during the ﬁrst
year of life (or before the infant starts walking). Diagno-
sis was made in 18% of cases during a statistical study
carried out among infants which were theoretically in
good health. Although rarely or not at all evaluated, the
impact of GER in infants upon the everyday life of the
parents is undoubtedly far from negligible. OBJECTIVE:
To evaluate the impact of GER in infants upon the quality
of life of both parents. METHODS: Within the context
of a cohort, 150 infants (under 3 months of age) were
monitored over a period of 6 months. On inclusion, a
generic scale (SF-12) are completed by both parents. The
completed questionnaires were returned in prepaid en-
velopes. RESULTS: The ﬁrst results concerned the ﬁrst 40
patients. Regarding the SF-12, the results were organised
in 2 scores: mental (MCS-12) and physical (PCS-12). The
norms observed in a standard American population are a
score of 50 (e-t:10) for each dimension. The SF-12 scores
for the fathers on inclusion were: PCS-12 = 52.6 (4.5) &
MCS-12 = 44.7 (8.4). The SF-12 scores for the mothers
on inclusion were: PCS-12 = 47.4 (7.7) & MCS-12 = 36.0
(9.8). Paired comparison of these results shows a modiﬁ-
cation in the quality of life of the mother compared with
that of the father. This difference is signiﬁcant in both
dimensions (p < 0.005). CONCLUSIONS: The quality of
life, evaluated by the SF12, of the parents whose child
suffered from gastroesophageal reﬂux was modiﬁed; this
phenomenon was particularly marked with regard to the
‘‘mental’’ component. The quality of life of the mother
was, in our study, more modiﬁed than that of the father.
The impact upon the quality of life of the immediate
entourage was, once again, highlighted. This impact
should be taken into consideration in the treatment of the
infant.
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ASSOCIATION BETWEEN SKIN TATTOOS AND
HEPATITIS B OF 1/2000 PRIVATES AT ADISORN
FORT HOSPITAL,THAILAND
Auamnoy Ti, Mekaroonreung S,Auamnoy Th
Chulalongkorn University, Bangkok,Thailand
OBJECTIVE: To determine whether there is association
between skin tattoos, Hepatitis-B and prisons, to investi-
gate risk behaviors for Hepatitis-B and to describe 
characteristics of person who have tattoos. METHODS:
This retrospective study consisted of a self-administered
survey, and an ELISA blood test for viral hepatitis B. The
study sample consisted of all 1/2001 privates at Adisorn
Fort Hospital Saraburi who had tattoos (n1 = 46) and
simple random sampling of another group of 46 volun-
teer privates who did not have tattoos. RESULTS: All pri-
vates (N = 92) were male, age 22.88b 1.41 years, 67
(72.8%) had graduated from elementary and high school,
29 were positive for Hepatitis-B antibodies (31.5%), 41
(44.6%) had sex with prostitutes, 3 (3.3%) did not 
use condom, 4 (4.3%) shared razors, 1 (1.1%) shared
needles, 25 (27.2%) had been in jail, 87 (94.6%) drank
alcohol, 43 (46.7%) had used amphetamines. Twenty
(28.6%) had tattoos on 2 arms. Ten (14.3%) had tattoo
on their back, 9 (19.6%) obtained their tattoos while in
prison, 15 (32.6%) had a tattoo that was greater than
20% of the body’s surface area. There was an association
between skin tattoo and Hepatitis B (Chi Square, p < .01,
OR: 15 :9, 95%CI: 1.97–128.16), and an association
between skin tattoo and having been in prison (Chi
Square, p < .01, OR: 6.3, 95%CI: 2.1–18.8), There was
no association between having been in jail and Hepatitis-
B. Logistic regression was employed to ﬁnd factors for
Hepatitis-B. The variables that were associated with
Hepatitis-B (<.05) were entered procedure to identify
association with Hepatitis-B. Hit rate was 87.9, Pseudo
R Square 0.464, Skin tattoos, a history of a family
member with Hepatitis-B, and sharing needles increased
the chance of getting Hepatitis-B. CONCLUSIONS:
There were associations between jails and tattoos and
viral hepatitis-B. Hygiene in tattoo’ shops should be con-
trolled by the government.
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TELITHROMYCIN (TEL) RESULTS IN FEWER
HOSPITALIZATIONS THAN AMOXICILLIN-
CLAVULANATE (AMC) IN THE OUTPATIENT
TREATMENT OF ACUTE EXACERBATIONS OF
CHRONIC BRONCHITIS (AECB)
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Nieman RB1
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OBJECTIVE: To compare the clinical efﬁcacy, AECB-
related hospitalization rates, and length of stay in hospi-
tal (LOS) in outpatients with AECB treated with either
TEL or AMC. METHODS: Outpatients with AECB 
(n = 325) were enrolled in a randomized, double-blind,
double-dummy, multicenter clinical study and received
either oral TEL 800mg once daily for 5 days or AMC
500/125mg 3 times daily for 10 days. Clinical and eco-
nomic outcomes were followed for 4 weeks. The primary
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statistical hypothesis was equivalence of clinical efﬁcacy
at the test of cure visit (Days 17..C21) in the per-protocol
populations. Study investigators who were blinded to the
treatment group at the time of admission assessed AECB-
related hospitalization events. RESULTS: Clinical cure
rates for the per-protocol populations of TEL- and AMC-
treated patients were similar and statistically equivalent
(TEL, 86.1% [n = 115]; AMC, 82.1% [n = 112]). The
number of AECB-related hospitalizations was 4 (2.5%)
for TEL vs 7 (4.4%) for AMC patients, with a shorter
total LOS for TEL vs AMC (28 vs 67 days, respectively).
The rate of hospital days per 100 patients was 17.5 for
TEL- vs 41.9 for AMC-treated patients. CONCLU-
SIONS: In this randomized, double-blind clinical trial,
treatment with TEL and AMC provided similar rates of
clinical efﬁcacy. However, fewer hospital admissions and
a reduced total LOS were observed for TEL-treated
patents. This shorter LOS may equate to cost savings in
the outpatient management of AECB.
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EFFECTIVENESS OF HAART IN REDUCING
VIRAL LOAD (VL) AMONG A LARGE COHORT
OF HIV-INFECTED PATIENTS—A SIGNIFICANT
UNMET NEED
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Squibb, Princeton, NJ, USA
OBJECTIVE: Highly Active Anti-Retroviral Therapy
(HAART) has signiﬁcantly reduced HIV-related morbid-
ity and mortality. Bartlett J et al. recently reviewed its efﬁ-
cacy in a clinical trial setting. The overall percentage of
patients with HIV RNA 400 copies/ml was 64% at 24
weeks, those with 50 copies/ml, 54%. However real-
world effectiveness data on viral control is lacking.
Whether efﬁcacious therapy can be translated into effec-
tive viral control in communities needs be evaluated. Our
objective was to address this issue by examining viral
control prevalence in a large HIV+ cohort. METHODS:
The study population was derived from Cerner HIV
Insight, a large national longitudinal database on US
HIV+ subjects. Adult HAART (PI-HAART, NNRTI-
HAART, NRTI-only-HAART) recipients during
1996–9/2002 were included. Subjects were followed until
week 24 of HAART or switch. Baseline VL was measured
30 days prior to HAART initiation. Study outcomes
were deﬁned as percentages of patients reaching (a) VL
 400 copies/ml, (b) VL  50 copies/ml, (c) CD4 
350/mm3, (d) a and c, and (e) b and c. Multivariate logis-
tic regression models including demographics, regimen
and baseline VL and CD4 count were constructed to iden-
tify signiﬁcant predictors of these study outcomes.
RESULTS: Analyses included 2776 subjects. Baseline
characteristics were summarized (mean age 40, 88%
male, 62% caucasian, 92% treatment naive, mean base-
line VL 131,877, mean CD4 304). At week 24/switch,
overall viral control was poor. For PI-HAART, the per-
centages of patients reaching outcomes (a)–(e) were 34,
30, 37, 18 and 16, respectively. For NNRTI-HAART: 33,
24, 53, 24 and 17, respectively. For NRTI-HAART: 20,
14, 42, 14 and 11, respectively. Multivariate analyses
identiﬁed age, regimen, and baseline VL and CD4 count
as signiﬁcant predictors. CONCLUSIONS: Compared to
clinical trial efﬁcacy, real-world viral control rates are
sub-optimal. More effective HIV therapy options appear
to be needed to manage this unmet need and improve
patient outcomes.
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THE INFLUENCE OF PRESCRIPTION DRUG
COVERAGE ON ANTIBIOTIC UTILIZATION IN
ACUTE RESPIRATORY TRACT INFECTIONS:
FINDINGS FROM THE MEDICAL EXPENDITURE
PANEL SURVEY (MEPS)
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OBJECTIVE: Recognizing the effect of prescription drug
coverage on the patient’s ability to obtain prescription
drugs is crucial and may play an important role in the
health care decision making process due to the associated
cost and the potential for misutilization. It is the objec-
tive of this study to provide speciﬁc information on the
inﬂuence of prescription drug coverage on antibiotic 
utilization in acute respiratory tract infections (RTIs).
METHODS: A retrospective study of (N = 3181) pre-
scription events associated with acute upper and lower
RTIs have been identiﬁed from the Household Compo-
nent (HC) of the 1996 Medical Expenditure Panel Survey
(MEPS). Cases selected included acute nasopharyngitis
(common cold), acute sinusitis, acute pharyngitis, acute
tonsillitis, acute laryngitis and tracheitis, acute upper
RTIs of multiple or unspeciﬁed sites, and acute bronchi-
tis and bronchiolitis. Antibiotic use and associated costs
were determined by selecting oral antibiotics and the sum
of payment associated with each prescription. Logistic
regression was used to evaluate prescription drug cover-
age effect on prescribing an antibiotic and on the type of
antibiotic prescribed. RESULTS: Antibiotics accounted
for 45.93% of the prescription events for acute RTIs, 
of which 25.46% were for high cost antibiotics. When
compared to patients with prescription drug coverage,
patients with no drug coverage were less likely to be pre-
scribed an antibiotic (OR: 0.499; 95% CI: 0.407–0.612),
and they were also less likely to receive a high cost antibi-
otic (OR: 0.096; 95% CI: 0.059–0.157). CONCLU-
SIONS: The results of the study indicate that, in acute
RTIs, the likelihood of being prescribed an antibiotic, 
that may be unnecessary, is greater when the patient has
prescription drug coverage. Providers of such coverage
should closely monitor prescribing patterns for acute
RTIs to avoid unnecessary cost and consequently, resis-
tance from such antibiotics.
